[1]
|
Huijgen, N.A., Laven, J.S., Labee, C.T., Louwers, Y.V., Willemsen, S.P. and Steegers-Theunissen, R.P. (2015) Are Dieting and Dietary Inadequacy a Second Hit in the Association with Polycystic Ovary Syndrome Severity? PloS ONE, 10, Article ID: e0142772. https://doi.org/10.1371/journal.pone.0142772
|
[2]
|
Palomba, S., Santagni, S., Falbo, A. and La Sala, G.B. (2015) Complications and Challenges Associated with Polycystic Ovary Syndrome: Current Perspectives. International Journal of Women’s Health, 7, 745-763.
https://doi.org/10.2147/IJWH.S70314
|
[3]
|
March, W.A., Moore, V.M., Willson, K.J., Phillips, D.I., Norman, R.J. and Davies, M.J. (2010) The Prevalence of Polycystic Ovary Syndrome in a Community Sample Assessed under Contrasting Diagnostic Criteria. Human Reproduction, 25, 544-551. https://doi.org/10.1093/humrep/dep399
|
[4]
|
Kamangar, F., Okhovat, J.P., Schmidt, T., Beshay, A., Pasch, L., Cedars, M.I., et al. (2015) Polycystic Ovary Syndrome: Special Diagnostic and Therapeutic Considerations for Children. Pediatric Dermatology, 32, 571-578.
https://doi.org/10.1111/pde.12566
|
[5]
|
Baldani, D.P., Skrgatic, L. and Ougouag, R. (2015) Polycystic Ovary Syndrome: Important Underrecognised Cardiometabolic Risk Factor in Reproductive-Age Women. International Journal of Endocrinology, 2015, 17.
https://doi.org/10.1155/2015/786362
|
[6]
|
Teede, H., Deeks, A. and Moran, L. (2010) Polycystic Ovary Syndrome: A Complex Condition with Psychological, Reproductive and Metabolic Manifestations That Impacts on Health across the Lifespan. BMC Medicine, 8, 41.
https://doi.org/10.1186/1741-7015-8-41
|
[7]
|
Legro, R.S., Arslanian, S.A., Ehrmann, D.A., Hoeger, K.M., Murad, M.H., Pasquali, R., et al. (2013) Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, 98, 4565-4592. https://doi.org/10.1210/jc.2013-2350
|
[8]
|
Riahinejad, S., Mirdamadi, A. and Alizadeh, E. (2015) Effects of Metformin Treatment on Homocysteine Levels and Metabolic Parameters of Women with Polycystic Ovary Syndrome. Journal of Family & Reproductive Health, 9, 172.
|
[9]
|
Barber, T.M. and Franks, S. (2013) Genetics of Polycystic Ovary Syndrome. In: Polycystic Ovary Syndrome, Karger Publishers, Basel, 28-39.
|
[10]
|
El Hayek, S., Bitar, L., Hamdar, L.H., Mirza, F.G. and Daoud, G. (2016) Poly Cystic Ovarian Syndrome: An Updated Overview. Frontiers in Physiology, 7, 124.
https://doi.org/10.3389/fphys.2016.00124
|
[11]
|
Zhuo, J.-M., Wang, H. and Praticò, D. (2011) Is Hyperhomocysteinemia an Alzheimer’s Disease (AD) Risk Factor, an AD Marker, or Neither? Trends in Pharmacological Sciences, 32, 562-571. https://doi.org/10.1016/j.tips.2011.05.003
|
[12]
|
Selhub, J. (1999) Homocysteine Metabolism. Annual Review of Nutrition, 19, 217-246. https://doi.org/10.1146/annurev.nutr.19.1.217
|
[13]
|
Collaboration, H.S. (2002) Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-Analysis. Jama, 288, 2015-2022.
https://doi.org/10.1001/jama.288.16.2015
|
[14]
|
Van Guldener, C. and Stehouwer, C. (2000) Hyperhomocysteinemia, Vascular Pathology, and Endothelial Dysfunction. Seminars in Thrombosis and Hemostasis. Thieme Medical Publishers, Inc., New York, 281-290.
https://doi.org/10.1055/s-2000-8472
|
[15]
|
Forges, T., Monnier-Barbarino, P., Alberto, J., Gueant-Rodriguez, R., Daval, J. and Gueant, J. (2007) Impact of Folate and Homocysteine Metabolism on Human Reproductive Health. Human Reproduction Update, 13, 225-238.
https://doi.org/10.1093/humupd/dml063
|
[16]
|
Del Bianco, A., Maruotti, G., Fulgieri, A., Celeste, T., Lombardi, L., Amato, N., et al. (2004) Recurrent Spontaneous Miscarriages and Hyperhomocysteinemia. Minerva Ginecologica, 56, 379-383.
|
[17]
|
Chakraborty, P., Goswami, S.K., Rajani, S., Sharma, S., Kabir, S.N., Chakravarty, B., et al. (2013) Recurrent Pregnancy Loss in Polycystic Ovary Syndrome: Role of Hyperhomocysteinemia and Insulin Resistance. PLoS ONE, 8, e64446.
https://doi.org/10.1371/journal.pone.0064446
|
[18]
|
Rotterdam, E. and Group A-SPCW (2004) Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome (PCOS). Human Reproduction (Oxford, England), 19, 41-47.
https://doi.org/10.1093/humrep/deh098
|
[19]
|
Al-Gareeb, A.I., Al-Amieer, W.S.A., Alkuraishy, H.M. and Al-Mayahi, T.J. (2016) Effect of Body Weight on Serum Homocysteine Level in Patients with Polycystic Ovarian Syndrome: A Case Control Study. International Journal of Reproductive BioMedicine, 14, 81-88.
|
[20]
|
Lin, Y.H., Huang, S.Y., Hsu, M.I., Chang, Y.C., Cheng, C.Y., Hsu, C.S., et al. (2013) Hyperhomocysteinaemia Is Associated with Biochemical Hyperandrogenaemia in Women with Reproductive Age. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 171, 314-318. https://doi.org/10.1016/j.ejogrb.2013.09.041
|
[21]
|
Carmina, E., Chu, M.C., Longo, R.A., Rini, G.B. and Lobo, R.A. (2005) Phenotypic Variation in Hyperandrogenic Women Influences the Findings of Abnormal Metabolic and Cardiovascular Risk Parameters. The Journal of Clinical Endocrinology and Metabolism, 90, 2545-2549. https://doi.org/10.1210/jc.2004-2279
|
[22]
|
Eskandari, Z., Sadrkhanlou, R.-A., Nejati, V. and Tizro, G. (2016) PCOS Women Show Significantly Higher Homocysteine Level, Independent to Glucose and E2 Level. International Journal of Reproductive BioMedicine, 14, 495-500.
|
[23]
|
Rekha, S., Patel, M., Pooja, G., Amita, D., Pushplata, S. and Natu, S. (2013) Correlation between Elevated Homocysteine Levels and Insulin Resistance in Infertile Women with or without Polycystic Ovary Syndrome in North Indian Population. International Journal of Medicine and Medical Sciences, 5, 116-123.
|
[24]
|
Altug Sen, T., Koken, R., Narci, A. and Yilmazer, M. (2011) Homocysteine and Ghrelin Link with Polcystic Ovary Syndrome in Relation to Obesity. Journal of Pediatric and Adolescent Gynecology, 24, 211-217.
https://doi.org/10.1016/j.jpag.2011.02.007
|
[25]
|
Hemati, T., Moghadami-Tabrizi, N., Davari-Tanha, F., Salmanian, B. and Javadian, P. (2011) High Plasma Homocysteine and Insulin Resistance in Patients with Polycystic Ovarian Syndrome. Iranian Journal of Reproductive Medicine, 9, 223-228.
|
[26]
|
Schachter, M., Raziel, A., Friedler, S., Strassburger, D., Bern, O. and Ron-El, R. (2003) Insulin Resistance in Patients with Polycystic Ovary Syndrome Is Associated with Elevated Plasma Homocysteine. Human Reproduction, 18, 721-727.
https://doi.org/10.1093/humrep/deg190
|
[27]
|
Kilic-Okman, T., Guldiken, S. and Kucuk, M. (2004) Relationship between Homocysteine and Insulin Resistance in Women with Polycystic Ovary Syndrome. Endocrine Journal, 51, 505-508. https://doi.org/10.1507/endocrj.51.505
|
[28]
|
Atamer, A., Demir, B., Bayhan, G., Atamer, Y., Ilhan, N. and Akkus, Z. (2008) Serum Levels of Leptin and Homocysteine in Women with Polycystic Ovary Syndrome and Its Relationship to Endocrine, Clinical and Metabolic Parameters. Journal of International Medical Research, 36, 96-105.
https://doi.org/10.1177/147323000803600113
|
[29]
|
Bayraktar, F., Dereli, D., Ozgen, A.G. and Yilmaz, C. (2004) Plasma Homocysteine Levels in Polycystic Ovary Syndrome and Congenital Adrenal Hyperplasia. Endocrine Journal, 51, 601-608. https://doi.org/10.1507/endocrj.51.601
|
[30]
|
Gupta, M.M., Chari, S., Chandankhede, M. and Ghike, S. (2013) Insulin Resistance and Homocysteine Levels in Patients with Polycystic Ovarian Syndrome. Journal of South Asian Federation of Obstetrics and Gynaecology, 5, 49-51.
https://doi.org/10.1111/j.1447-0756.1977.tb00351.x
|
[31]
|
Badawy, A., State, O., El Gawad, S. and El Aziz, O.A. (2007) Plasma Homocysteine and Polycystic Ovary Syndrome: The Missed Link. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 131, 68-72.
https://doi.org/10.1016/j.ejogrb.2006.10.015
|
[32]
|
Oktem, M., Ozcimen, E.E., Uckuyu, A., Esinler, I., Pamuk, B., Bayraktar, N., et al. (2009) Polycystic Ovary Syndrome Is Associated with Elevated Plasma Soluble CD40 Ligand, a Marker of Coronary Artery Disease. Fertility and Sterility, 91, 2545-2550. https://doi.org/10.1016/j.fertnstert.2008.03.039
|
[33]
|
Salehpour, S., Ozra Manzor-al-ajdad, M., Elham Neisani Samani, M. and Abadi, A. (2011) Evaluation of Homocysteine Levels in Patients with Polycystic Ovarian Syndrome. International Journal of Fertility & Sterility, 4, 168-171.
|
[34]
|
Topcu, S., Caliskan, M., Ozcimen, E.E., Tok, D., Uckuyu, A., Erdogan, D., et al. (2006) Do Young Women with Polycystic Ovary Syndrome Show Early Evidence of Preclinical Coronary Artery Disease? Human Reproduction, 21, 930-935.
https://doi.org/10.1093/humrep/dei431
|
[35]
|
Esmaeilzadeh, S., Tahmasbpour, E. and Gholinezhad-Chari, M. (2017) Hyperhomocysteinemia, Insulin Resistance and Body Mass Index in Iranian Young Women with Polycystic Ovary Syndrome. Middle East Fertility Society Journal, 22, 149-155.
https://doi.org/10.1016/j.mefs.2017.01.007
|
[36]
|
Jacobsen, D. (2002) Unexpected Inverse Relationship between Insulin Resistance and Serum Homocysteine in Healthy Subjects. Physiological Research, 51, 93-98.
|
[37]
|
Moti, M., Amini, L., Ardakani, S.S.M., Kamalzadeh, S. and Masoomikarimi, M. (2015) Oxidative Stress and Anti-Oxidant Defense System in Iranian Women with Polycystic Ovary Syndrome. Iranian Journal of Reproductive Medicine, 13, 373-378.
|
[38]
|
Rajagopal, G., Reddy, A.P., Venkata Harinarayan, C., Suresh, V., Bitla, A., Pvlnr, S., et al. (2012) Effect of Lifestyle Modification and Metformin Therapy on Emerging Cardiovascular Risk Factors in Overweight Indian Women with Polycystic Ovary Syndrome. Metabolic Syndrome and Related Disorders, 10, 273-279.
https://doi.org/10.1089/met.2011.0127
|
[39]
|
Caglar, G.S., Oztas, E., Karadag, D., Pabuccu, R. and Demirtas, S. (2011) Ischemia-Modified Albumin and Cardiovascular Risk Markers in Polycystic Ovary Syndrome with or without Insulin Resistance. Fertility and Sterility, 95, 310-313.
https://doi.org/10.1016/j.fertnstert.2010.06.092
|
[40]
|
Yilmaz, M., Bukan, N., Ayvaz, G., Karakoc, A., Toruner, F., Cakir, N., et al. (2005) The Effects of Rosiglitazone and Metformin on Oxidative Stress and Homocysteine Levels in Lean Patients with Polycystic Ovary Syndrome. Human Reproduction, 20, 3333-3340. https://doi.org/10.1093/humrep/dei258
|
[41]
|
Maleedhu, P., Kodumuri, P.K. and Devi, D.V. (2014) Status of Homocysteine in Polycystic Ovary Syndrome (PCOS). Journal of Clinical and Diagnostic Research, 8, 31-33.
|
[42]
|
Mohamadin, A.M., Habib, F.A. and Al-Saggaf, A.A. (2010) Cardiovascular Disease Markers in Women with Polycystic Ovary Syndrome with Emphasis on Asymmetric Dimethylarginine and Homocysteine. Annals of Saudi Medicine, 30, 278-283.
https://doi.org/10.4103/0256-4947.65255
|
[43]
|
Karaer, A., Cavkaytar, S., Mert, I., Buyukkagnici, U. and Batioglu, S. (2010) Cardiovascular Risk Factors in Polycystic Ovary Syndrome. Journal of Obstetrics and Gynaecology, 30, 387-392. https://doi.org/10.3109/01443611003763408
|
[44]
|
Pamuk, B.O., Torun, A.N., Kulaksizoglu, M., Ertugrul, D., Ciftci, O., Kulaksizoglu, S., et al. (2010) Asymmetric Dimethylarginine Levels and Carotid Intima-Media Thickness in Obese Patients with Polycystic Ovary Syndrome and Their Relationship to Metabolic Parameters. Fertility and Sterility, 93, 1227-1233.
https://doi.org/10.1016/j.fertnstert.2008.10.073
|
[45]
|
Sills, E.S., Genton, M.G., Perloe, M., Schattman, G.L., Bralley, J.A. and Tucker, M.J. (2001) Plasma Homocysteine, Fasting Insulin, and Androgen Patterns among Women with Polycystic Ovaries and Infertility. Journal of Obstetrics and Gynaecology Research, 27, 163-168. https://doi.org/10.1111/j.1447-0756.2001.tb01241.x
|
[46]
|
Morgante, G., la Marca, A., Setacci, F., Setacci, C., Petraglia, F. and De Leo, V. (2002) The Cardiovascular Risk Factor Homocysteine Is Not Elevated in Young Women with Hyperandrogenism or Hypoestrogenism. Gynecologic and Obstetric Investigation, 53, 200-203. https://doi.org/10.1159/000064561
|
[47]
|
Orio, F., Palomba, S., Di Biase, S., Colao, A., Tauchmanova, L., Savastano, S., et al. (2003) Homocysteine Levels and C677T Polymorphism of Methylenetetrahydrofolate Reductase in Women with Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology and Metabolism, 88, 673-679.
https://doi.org/10.1210/jc.2002-021142
|
[48]
|
Mancini, F., Cianciosi, A., Reggiani, G.M., Facchinetti, F., Battaglia, C. and de Aloysio, D. (2009) Endothelial Function and Its Relationship to Leptin, Homocysteine, and Insulin Resistance in Lean and Overweight Eumenorrheic Women and PCOS Patients: A Pilot Study. Fertility and Sterility, 91, 2537-2544.
https://doi.org/10.1016/j.fertnstert.2008.03.023
|
[49]
|
Arikan, S., Bahceci, M., Tuzcu, A., Kale, E. and Gokalp, D. (2010) Serum Resistin and Adiponectin Levels in Young Non-Obese Women with Polycystic Ovary Syndrome. Gynecological Endocrinology, 26, 161-166.
https://doi.org/10.3109/09513590903247816
|
[50]
|
Moini, A., Sarrafion, F., Ziaei, S., Faghihzadeh, S. and Arabipoor, A. (2011) A Possible Role for Familial Thrombophilia in Women with Polycystic Ovarian Syndrome. Gynecological Endocrinology, 27, 80-85.
https://doi.org/10.3109/09513590.2010.488768
|
[51]
|
Welch, G.N. and Loscalzo, J. (1998) Homocysteine and Atherothrombosis. New England Journal of Medicine, 338, 1042-1050.
https://doi.org/10.1056/NEJM199804093381507
|
[52]
|
Dicker-brown, A., Fonseca, V.A., Fink, L.M. and Kern, P.A. (1999) The Effect of Glucose and Insulin on the Activity of Enzymes in Homocysteine Metabolism. Diabetes, 48, SA135.
|
[53]
|
Traub, M.L. (2011) Assessing and Treating Insulin Resistance in Women with Polycystic Ovarian Syndrome. World Journal of Diabetes, 2, 33-40.
https://doi.org/10.4239/wjd.v2.i3.33
|
[54]
|
Sahin, Y., Unluhizarci, K., Yilmazsoy, A., Yikilmaz, A., Aygen, E. and Kelestimur, F. (2007) The Effects of Metformin on Metabolic and Cardiovascular Risk Factors in Nonobese Women with Polycystic Ovary Syndrome. Clinical Endocrinology, 67, 904-908. https://doi.org/10.1111/j.1365-2265.2007.02985.x
|
[55]
|
Haydardedeoglu, B., Simsek, E., Kilicdag, E.B. and Bagis, T. (2009) Metabolic and Endocrine Effects of Metformin and Metformin plus Cyclic Medroxyprogesterone Acetate in Women with Polycystic Ovary Syndrome. International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics, 105, 32-35. https://doi.org/10.1016/j.ijgo.2008.11.039
|
[56]
|
Vrbikova, J., Bicíková, M., Tallova, J., Hill, M. and Starka, L. (2002) Homocysteine and Steroids Levels in Metformin Treated Women with Polycystic Ovary Syndrome. Experimental and Clinical Endocrinology & Diabetes, 110, 74-76.
https://doi.org/10.1055/s-2002-23489
|
[57]
|
Kilicdag, E.B., Bagis, T., Zeyneloglu, H.B., Tarim, E., Aslan, E., Haydardedeoglu, B., et al. (2005) Homocysteine Levels in Women with Polycystic Ovary Syndrome Treated with Metformin versus Rosiglitazone: A Randomized Study. Human Reproduction, 20, 894-899. https://doi.org/10.1093/humrep/deh700
|
[58]
|
Obeid, R. (2014) Metformin Causing Vitamin B12 Deficiency: A Guilty Verdict without Sufficient Evidence. Diabetes Care, 37, e22-e32.
https://doi.org/10.2337/dc13-2278
|
[59]
|
Xu, L., Huang, Z., He, X., Wan, X., Fang, D. and Li, Y. (2013) Adverse Effect of Metformin Therapy on Serum Vitamin B12 and Folate: Short-Term Treatment Causes Disadvantages? Medical Hypotheses, 81, 149-151.
https://doi.org/10.1016/j.mehy.2013.05.025
|
[60]
|
Palomba, S., Falbo, A., Giallauria, F., Russo, T., Tolino, A., Zullo, F., et al. (2010) Effects of Metformin with or without Supplementation with Folate on Homocysteine Levels and Vascular Endothelium of Women with Polycystic Ovary Syndrome. Diabetes Care, 33, 246-251. https://doi.org/10.2337/dc09-1516
|
[61]
|
Kilic, S., Yilmaz, N., Zulfikaroglu, E., Erdogan, G., Aydin, M. and Batioglu, S. (2011) Inflammatory-Metabolic Parameters in Obese and Nonobese Normoandrogenemic Polycystic Ovary Syndrome during Metformin and Oral Contraceptive Treatment. Gynecological Endocrinology, 27, 622-629.
https://doi.org/10.3109/09513590.2010.530706
|
[62]
|
Kaya, C., Cengiz, S.D., Berker, B., Demirtas, S., Cesur, M. and Erdogan, G. (2009) Comparative Effects of Atorvastatin and Simvastatin on the Plasma Total Homocysteine Levels in Women with Polycystic Ovary Syndrome: A Prospective Randomized Study. Fertility and Sterility, 92, 635-642.
https://doi.org/10.1016/j.fertnstert.2008.06.006
|
[63]
|
Harmanci, A., Cinar, N., Bayraktar, M. and Yildiz, B.O. (2013) Oral Contraceptive plus Antiandrogen Therapy and Cardiometabolic Risk in Polycystic Ovary Syndrome. Clinical Endocrinology, 78, 120-125.
https://doi.org/10.1111/j.1365-2265.2012.04466.x
|
[64]
|
Cagnacci, A., Tirelli, A., Renzi, A., Paoletti, A.M. and Volpe, A. (2006) Effects of Two Different Oral Contraceptives on Homocysteine Metabolism in Women with Polycystic Ovary Syndrome. Contraception, 73, 348-351.
https://doi.org/10.1016/j.contraception.2005.09.011
|
[65]
|
Gul, O.B., Somunkiran, A., Yucel, O., Demirci, F. and Ozdemir, I. (2008) The Effect of Ethinyl Estradiol-Cyproterone Acetate Treatment on Homocysteine Levels in Women with Polycystic Ovary Syndrome. Archives of Gynecology and Obstetrics, 277, 25-30. https://doi.org/10.1007/s00404-007-0401-x
|
[66]
|
Luque-Ramírez, M., Mendieta-Azcona, C. and del Rey Sanchez, J. (2009) Effects of an Antiandrogenic OCP’s Compared with Metformin on Blood Coagulation Tests and Endothelial Function in Women with the PCOS, Influence of Obesity and Smoking. European Journal of Endocrinology, 160, 469-480.
https://doi.org/10.1530/EJE-08-0725
|
[67]
|
Randeva, H.S., Lewandowski, K.C., Drzewoski, J.Z., Brooke-Wavell, K., O’callaghan, C., Czupryniak, L., et al. (2002) Exercise Decreases Plasma Total Homocysteine in Overweight Young Women with Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism, 87, 4496-4501.
https://doi.org/10.1210/jc.2001-012056
|
[68]
|
Kucuk, M. and Kilic-Okman, T. (2005) Hormone Profiles and Clinical Outcome after Laparoscopic Ovarian Drilling in Women with Polycystic Ovary Syndrome. Medical Science Monitor, 11, CR29-CR34.
|
[69]
|
Van Baal, W.M., Smolders, R.G., Van der Mooren, M.J., Teerlink, T. and Kenemans, P. (1999) Hormone Replacement Therapy and Plasma Homocysteine Levels. Obstetrics & Gynecology, 94, 485-491.
https://doi.org/10.1097/00006250-199910000-00001
|